Ginkgo BioWorks Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Ginkgo BioWorks Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10551
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ginkgo BioWorks Inc (Ginkgo BioWorks) is a biotechnology company which offers automated organism engineering, enzyme discovery and cultured fragrances. The company build’s foundries to scale the process of organism engineering using software and hardware automation tools. It produces ingredients through fermentation with engineered yeasts for perfumes, foods, cosmetics markets; discover new enzymes used in applications including cheesemaking, pharmaceuticals, and stonewashed jeans. It also uses laboratory automation synthesis, software and automation, and high performance analytical tools to produce these products. The company partners with leading bio-industrial fermentation companies such as Ajinomoto and Cargill to improve the efficiency of the microbial strains. Ginkgo BioWorks is headquartered in Boston, Massachusetts, the US.

Ginkgo BioWorks Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Gen9 Raises USD25 Million in Series C Financing 10
Ginkgo Bioworks Secures USD0.12 Million in Seed Funding 11
Gen9 Raises US$0.4 Million In Venture Financing 12
Partnerships 13
Synlogic Enters into Partnership Agreement with Ginkgo BioWorks 13
Licensing Agreements 14
Synthetic Genomics Enters Licensing Agreement with Gen9 for Synthetic Biology Technology Patents 14
Acquisition 15
Ginkgo Bioworks Acquires Gen9 15
Agilent Technologies Acquires Minority Stake In Gen9 For US$21 Million 16
Ginkgo BioWorks Inc – Key Competitors 17
Ginkgo BioWorks Inc – Key Employees 18
Ginkgo BioWorks Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Strategy And Business Planning 20
Oct 24, 2018: Ginkgo Bioworks opens Bioworks4, adds new tools for the rapid genetic engineering of mammalian cells 20
Corporate Communications 21
Jun 29, 2017: Ginkgo Bioworks Announces New Chief Business Officer and Head of Metabolic Engineering to Support Business Growth 21
Jan 06, 2017: Christian Henry Joins Ginkgo Bioworks Board of Directors 22
Other Significant Developments 23
Jun 27, 2018: Ginkgo Bioworks Announces Biosecurity Initiative, Using Deep Learning to Reduce the Global Threat of Biological Weapons and Infectious Disease 23
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Key Facts 2
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ginkgo BioWorks Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Gen9 Raises USD25 Million in Series C Financing 10
Ginkgo Bioworks Secures USD0.12 Million in Seed Funding 11
Gen9 Raises US$0.4 Million In Venture Financing 12
Synlogic Enters into Partnership Agreement with Ginkgo BioWorks 13
Synthetic Genomics Enters Licensing Agreement with Gen9 for Synthetic Biology Technology Patents 14
Ginkgo Bioworks Acquires Gen9 15
Agilent Technologies Acquires Minority Stake In Gen9 For US$21 Million 16
Ginkgo BioWorks Inc, Key Competitors 17
Ginkgo BioWorks Inc, Key Employees 18
Ginkgo BioWorks Inc, Subsidiaries 19

List of Figures
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Ginkgo BioWorks Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • RCL Foods Ltd (RCL):企業の財務・戦略的SWOT分析
    RCL Foods Ltd (RCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Suzhou Xinrong Best Medical Instrument Co Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Suzhou Xinrong Best Medical Instrument Co Ltd (Suzhou Xinrong) is a medical device company that manufactures orthopedic medical instruments. The company offers products such as medullary cavity plug, acetabular screws, metal ball head, stem and titanium plate anterior thoracolumbar fixed equ …
  • Isarna Therapeutics GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Isarna Therapeutics GmbH (Isarna), formerly Antisense Pharma GmbH is a healthcare products provider that develops products for ophthalmic, fibrotic diseases and cancers. The company offers antisense technology based drugs that treats aggressive tumor diseases. Its product include TGF-ß, a in …
  • InterDigital, Inc. (IDCC):企業の財務・戦略的SWOT分析
    InterDigital, Inc. (IDCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Otsuka Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Otsuka Pharmaceutical Co Ltd (OPC), a subsidiary of Otsuka Holdings Co Ltd is a provider of healthcare products. The company offers products which include pocari sweat, pocari sweat ion water, oronamin c, calorie mate, nature made, jerubure, jarinea, five mini, amino-value, enerugen, jog mat …
  • Territorial Generation Company No. 11:企業の戦略的SWOT分析
    Territorial Generation Company No. 11 - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Coventry Group Ltd (CYG):企業の財務・戦略的SWOT分析
    Coventry Group Ltd (CYG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cadence Design Systems, Inc. (CDNS):企業の財務・戦略的SWOT分析
    Cadence Design Systems, Inc. (CDNS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Michael Foods, Inc.:企業の戦略・SWOT・財務情報
    Michael Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary Michael Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Saipem SpA:企業の戦略・SWOT・財務分析
    Saipem SpA - Strategy, SWOT and Corporate Finance Report Summary Saipem SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Alabama Power Co:企業の戦略的SWOT分析
    Alabama Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Recursion Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Recursion Pharmaceuticals Inc (Recursion Pharmaceuticals) is a biotechnology company that develops novel therapies for the treatment of rare genetic diseases. The company’s pipeline products include novel drugs for various diseases such as ataxia-telangiectasia, cerebral cavernous malformati …
  • Power Finance Corporation Ltd.:企業の戦略・SWOT・財務分析
    Power Finance Corporation Ltd. - Strategy, SWOT and Corporate Finance Report Summary Power Finance Corporation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Crossject SA (ALCJ):企業の財務・戦略的SWOT分析
    Summary Crossject SA (Crossject) is a medical device company that develops injection systems. The company’s pipeline products include sumatriptan for the treatment of migraines and cluster headaches; adrenaline for the treatment of anaphylactic shock; hydrocortisone for the treatment of acute adrena …
  • China Sunergy Co., Ltd. (CSUN):企業の財務・戦略的SWOT分析
    China Sunergy Co., Ltd. (CSUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • FUJIFILM Medical Systems USA Inc:企業の戦略的SWOT分析
    FUJIFILM Medical Systems USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Taiwan Sugar Corp:企業の戦略的SWOT分析
    Taiwan Sugar Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • VOCO GmbH:企業の戦略的SWOT分析
    VOCO GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Sanmina Corporation:企業の戦略・SWOT・財務情報
    Sanmina Corporation - Strategy, SWOT and Corporate Finance Report Summary Sanmina Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Black Stone Minerals LP (BSM):企業の財務・戦略的SWOT分析
    Summary Black Stone Minerals LP (Black Stone) is a mining and minerals exploration and development company that explores and produces mineral deposits. The company's services include participating on a working interest basis when economics are favorable, leasing minerals to exploration and productio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆